Geneos Wealth Management Inc. Buys 12,900 Shares of Schrödinger, Inc. (NASDAQ:SDGR)

Geneos Wealth Management Inc. grew its stake in Schrödinger, Inc. (NASDAQ:SDGRFree Report) by 144.7% in the fourth quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 21,816 shares of the company’s stock after buying an additional 12,900 shares during the period. Geneos Wealth Management Inc.’s holdings in Schrödinger were worth $781,000 at the end of the most recent reporting period.

A number of other institutional investors have also recently made changes to their positions in SDGR. SG Americas Securities LLC raised its stake in shares of Schrödinger by 8.4% during the fourth quarter. SG Americas Securities LLC now owns 5,125 shares of the company’s stock valued at $183,000 after acquiring an additional 397 shares during the last quarter. Spire Wealth Management raised its position in Schrödinger by 66.7% during the 3rd quarter. Spire Wealth Management now owns 1,000 shares of the company’s stock valued at $28,000 after purchasing an additional 400 shares during the last quarter. Motley Fool Asset Management LLC lifted its holdings in Schrödinger by 2.0% in the 3rd quarter. Motley Fool Asset Management LLC now owns 29,402 shares of the company’s stock worth $831,000 after buying an additional 570 shares during the period. US Bancorp DE increased its stake in shares of Schrödinger by 69.2% during the first quarter. US Bancorp DE now owns 1,932 shares of the company’s stock valued at $66,000 after buying an additional 790 shares during the period. Finally, PNC Financial Services Group Inc. raised its holdings in shares of Schrödinger by 1,676.0% during the second quarter. PNC Financial Services Group Inc. now owns 888 shares of the company’s stock valued at $44,000 after acquiring an additional 838 shares in the last quarter. Institutional investors own 79.05% of the company’s stock.

Insider Buying and Selling at Schrödinger

In related news, insider Robert Lorne Abel sold 1,205 shares of Schrödinger stock in a transaction on Monday, February 12th. The stock was sold at an average price of $27.55, for a total value of $33,197.75. Following the completion of the sale, the insider now owns 9,340 shares of the company’s stock, valued at $257,317. The sale was disclosed in a filing with the Securities & Exchange Commission, which is accessible through this hyperlink. In related news, insider Robert Lorne Abel sold 1,205 shares of Schrödinger stock in a transaction on Monday, February 12th. The stock was sold at an average price of $27.55, for a total transaction of $33,197.75. Following the transaction, the insider now directly owns 9,340 shares in the company, valued at $257,317. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available through the SEC website. Also, COO Kenneth Patrick Lorton sold 901 shares of the company’s stock in a transaction dated Monday, February 12th. The stock was sold at an average price of $28.29, for a total value of $25,489.29. Following the completion of the sale, the chief operating officer now owns 36,487 shares of the company’s stock, valued at approximately $1,032,217.23. The disclosure for this sale can be found here. In the last ninety days, insiders sold 3,651 shares of company stock worth $102,395. Insiders own 7.60% of the company’s stock.

Schrödinger Trading Down 0.5 %

Schrödinger stock opened at $27.38 on Friday. The business’s fifty day simple moving average is $27.46 and its two-hundred day simple moving average is $28.48. Schrödinger, Inc. has a 12 month low of $20.76 and a 12 month high of $59.24. The company has a market capitalization of $1.98 billion, a price-to-earnings ratio of 43.46 and a beta of 1.57.

Schrödinger (NASDAQ:SDGRGet Free Report) last announced its quarterly earnings data on Wednesday, February 28th. The company reported ($0.32) earnings per share for the quarter, topping analysts’ consensus estimates of ($0.44) by $0.12. The company had revenue of $74.10 million during the quarter, compared to analyst estimates of $79.12 million. Schrödinger had a net margin of 18.79% and a negative return on equity of 23.58%. The firm’s revenue for the quarter was up 30.5% on a year-over-year basis. During the same period in the previous year, the business earned ($0.39) EPS. On average, equities research analysts predict that Schrödinger, Inc. will post -2.73 EPS for the current year.

Analyst Upgrades and Downgrades

Several analysts recently weighed in on the stock. Bank of America cut their price target on shares of Schrödinger from $38.00 to $32.00 and set a “neutral” rating on the stock in a report on Thursday, February 29th. Citigroup reduced their price target on shares of Schrödinger from $47.00 to $39.00 and set a “buy” rating on the stock in a research report on Thursday, February 29th. KeyCorp cut their price objective on Schrödinger from $38.00 to $33.00 and set an “overweight” rating on the stock in a research report on Thursday, February 29th. TD Cowen started coverage on Schrödinger in a research report on Friday, January 26th. They issued an “outperform” rating and a $42.00 target price for the company. Finally, Craig Hallum dropped their price target on Schrödinger from $40.00 to $35.00 and set a “buy” rating on the stock in a research report on Friday, January 19th. Three equities research analysts have rated the stock with a hold rating and six have issued a buy rating to the company. According to MarketBeat.com, Schrödinger presently has a consensus rating of “Moderate Buy” and an average price target of $43.50.

View Our Latest Stock Analysis on Schrödinger

Schrödinger Company Profile

(Free Report)

Schrödinger, Inc, together with its subsidiaries, develops physics-based computational platform that enables discovery of novel molecules for drug development and materials applications. The company operates in two segments, Software and Drug Discovery. The Software segment is focused on licensing its software to transform molecular discovery for life sciences and materials science industries.

Featured Articles

Want to see what other hedge funds are holding SDGR? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Schrödinger, Inc. (NASDAQ:SDGRFree Report).

Institutional Ownership by Quarter for Schrödinger (NASDAQ:SDGR)

Receive News & Ratings for Schrödinger Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Schrödinger and related companies with MarketBeat.com's FREE daily email newsletter.